Almost $12 million in verdicts awarded to three Florida women who developed debilitating bowel problems after using the acne drug Accutane were thrown out on appeal in a decision that could impact similar suits.
Ruling in three cases brought in New Jersey, the Appellate Division held that the claims were not time-barred but controlling Florida precedent on proximate causation entitled drug makers Hoffmann-La Roche Inc. and Roche Laboratories Inc. to judgment as a matter of law.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
